Linked from

The 178 pages that link to Pharmacokinetics, each with the reason it gives.

• Biological half-lifeNarrower topic: Biological half-life summarizes one part of a substance’s movement through the body.

• LamotrigineNarrower topic: Lamotrigine’s clearance changes substantially with interacting medicines and helps determine dosing.

• LSDRelated: LSD’s slow clearance helps account for its long-lasting effects.

• BiosimilarRelated: Comparative studies assess whether the products behave similarly in the body.

• CeftriaxoneNarrower topic: Ceftriaxone’s long elimination half-life helps permit once-daily dosing.

• CYP2D6Narrower topic: CYP2D6 contributes to drug clearance and therefore can alter concentration-time profiles.

• Efflux pumpRelated: Efflux transporters affect drug absorption and tissue exposure in the body.

• EndocrinologyRelated: Drug handling shapes dosing schedules for many endocrine therapies.

• FluoxetineNarrower topic: Fluoxetine’s long half-life shapes dosing, interactions, and discontinuation.

• GLP-1 receptor agonistRelated: Long-acting formulations depend on pharmacokinetic designs that permit weekly or daily dosing.

• Herb–drug interactionNarrower topic: Many herb–drug interactions change the amount of medicine reaching its site of action.

• MethylphenidateRelated: Absorption and elimination help explain why formulations produce different durations of effect.

• SertralineRelated: Absorption and metabolism shape sertraline’s dosing and duration.

• Tranexamic acidRelated: Its renal elimination and route-dependent exposure guide safe tranexamic acid dosing.

• VenlafaxineRelated: Venlafaxine's metabolism and short elimination half-life help explain dosing and withdrawal considerations.

• Dosage formNarrower topic: Dosage-form design can change the concentration-time profile that pharmacokinetics describes.

• ErythromycinRelated: Erythromycin’s absorption and metabolism shape its dosing and interaction profile.

• Gender-affirming hormone therapyNarrower topic: Hormone formulation and route affect how medication levels change between doses.

• LevothyroxineRelated: Levothyroxine's slow elimination helps explain its long dosing interval and delayed response to changes.

• Psychiatric medicationRelated: Drug concentration over time helps determine dosing schedules and delayed or prolonged effects.

• PsychopharmacologyRelated: Drug concentration over time helps determine onset, duration, and dosing.

• Treatment-resistant depressionRelated: Drug interactions or rapid metabolism can reduce exposure and mimic an ineffective treatment.

• AntidoteRelated: A poison's movement through the body shapes whether an antidote can reach it in time.

• Biologic therapyRelated: Large biological molecules have distinctive distribution and clearance patterns that shape dosing.

• DiphenhydramineNarrower topic: Absorption, metabolism, and elimination shape diphenhydramine’s duration and timing of effects.

• Drug developmentRelated: These measurements help determine dosing and interpret exposure in development studies.

• Drug overdoseNarrower topic: These processes determine how quickly a drug accumulates and how long toxic effects persist.

• Active metaboliteNarrower topic: Metabolite formation and clearance shape the timing and duration of drug effects.

• AmlodipineNarrower topic: Amlodipine’s gradual absorption and long elimination half-life shape its once-daily dosing.

• AripiprazoleNarrower topic: Its long half-life and metabolism shape aripiprazole dosing and interactions.

• CetirizineRelated: Cetirizine’s absorption and renal elimination shape its dosing and duration of action.

• Drug absorptionNarrower topic: Absorption is the entry phase in the processes pharmacokinetics describes.

• FamotidineNarrower topic: Famotidine’s absorption and kidney clearance shape its dosing and duration.

• Inhalational anestheticNarrower topic: It supplies the general framework for inhaled anesthetic uptake and washout.

• PharmacotherapyRelated: These processes determine drug concentrations over time and inform dosing.

• ProgestinRelated: Differences in these properties help explain why progestins have distinct doses and dosing schedules.

• Psychoactive drugRelated: Absorption and clearance help determine how quickly effects begin and how long they last.

• Set and settingCompared with: Changes in drug concentration differ from changes caused by mindset or surroundings.

• SpironolactoneRelated: Its active metabolites and relatively slow onset help explain dosing and effect timing.

• Subcutaneous injectionNarrower topic: It explains how an injection route shapes medicine concentration over time.

• Antifungal drugRelated: Drug exposure at the infected tissue affects whether an antifungal regimen can work.

• BiopharmaceuticalRelated: Large biological molecules often have different absorption routes and clearance patterns from small-molecule drugs.

• CannabidiolRelated: CBD’s absorption and breakdown vary with formulation, food, and route of administration.

• Statin-associated muscle symptomsRelated: Differences in drug exposure can affect the likelihood of muscle adverse effects.

• Adenosine receptor antagonistNarrower topic: Exposure and duration determine how long receptor blockade persists.

• AnesthesiologyRelated: Drug timing and dosing depend on how anesthetic agents move through and leave the body.

• Developmental toxicityRelated: Maternal and fetal handling of an agent shapes the dose reaching developing tissues.

• DextromethorphanNarrower topic: Its metabolism and clearance help explain differences in dextromethorphan effects.

• ExtrapolationRelated: Researchers can estimate drug exposure beyond sampled times using concentration curves.

• MescalineRelated: Its relatively slow onset and long duration reflect how the body handles mescaline.